{"nct_id":"NCT05029609","title":"Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS","status":"WITHDRAWN","status_verified_date":"2022-02","start_date":"2021-10","start_date_type":"ESTIMATED","primary_completion_date":"2022-11","primary_completion_date_type":"ESTIMATED","completion_date":"2022-12","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["TLSA"]}